These findings confirm that tau-induced glymphatic dysfunction is mediated by astrocytic contractility and that targeting this pathway can restore vascular tone and clearance function, highlighting its potential as a therapeutic avenue in AD. This evidence concerns the gene MAPT and Alzheimer disease.